Scientists at @Science4America @MGHCancerCenter @Genentech@BroadInstitute lay out a blueprint in @NatureRevCancer for a national system to facilitate routine “cancer recurrence interception trials.” https://t.co/tBTM4f3DvC
The trials will test new drugs in patients with a high-risk of cancer recurrence, based on the presence of circulating tumor DNA, before clinical or radiographic evidence of recurrence is apparent.
The system could speed drug development for solid cancers — enabling faster, smaller, and cheaper clinical trials by engaging the more than 100,000 patients who have been treated for an early-stage cancer but remain at risk that the cancer will recur.
Science for America, a new solutions incubator, unveils two promising approaches for fusion power that could speed progress, reduce cost, and simplify engineering for clean energy production to address the climate crisis. https://t.co/OjcMuoJ4ai
#fusion#Science